"Chelating Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS.
| Descriptor ID |
D002614
|
| MeSH Number(s) |
D27.505.519.914.500 D27.720.832.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Chelating Agents".
Below are MeSH descriptors whose meaning is more specific than "Chelating Agents".
This graph shows the total number of publications written about "Chelating Agents" by people in this website by year, and whether "Chelating Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 2 | 2 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 4 | 4 |
| 2002 | 1 | 1 | 2 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 1 | 2 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 2 | 3 | 5 |
| 2010 | 1 | 1 | 2 |
| 2011 | 1 | 2 | 3 |
| 2012 | 0 | 3 | 3 |
| 2013 | 4 | 1 | 5 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chelating Agents" by people in Profiles.
-
Inhibition of amyloid beta toxicity in zebrafish with a chaperone-gold nanoparticle dual strategy. Nat Commun. 2019 08 22; 10(1):3780.
-
Differences in the Relaxometric Properties of Regioisomeric Benzyl-DOTA Bifunctional Chelators: Implications for Molecular Imaging. Bioconjug Chem. 2019 05 15; 30(5):1530-1538.
-
The iron chelating agent, deferoxamine detoxifies Fe(Salen)-induced cytotoxicity. J Pharmacol Sci. 2017 Aug; 134(4):203-210.
-
Hepatic Encephalopathy: Pharmacological Therapies Targeting Ammonia. Semin Liver Dis. 2016 Feb; 36(1):48-55.
-
Isomerism in benzyl-DOTA derived bifunctional chelators: implications for molecular imaging. Bioconjug Chem. 2015 Feb 18; 26(2):338-44.
-
Targeted chelation therapy with EDTA-loaded albumin nanoparticles regresses arterial calcification without causing systemic side effects. J Control Release. 2014 Dec 28; 196:79-86.
-
Efficacy of reversal of aortic calcification by chelating agents. Calcif Tissue Int. 2013 Nov; 93(5):426-35.
-
The role of a Schiff base scaffold, N-(2-hydroxy acetophenone) glycinate-in overcoming multidrug resistance in cancer. Eur J Pharm Sci. 2014 Jan 23; 51:96-109.
-
Selective induction of apoptosis in various cancer cells irrespective of drug sensitivity through a copper chelate, copper N-(2 hydroxy acetophenone) glycinate: crucial involvement of glutathione. Biometals. 2013 Jun; 26(3):517-34.
-
Picture of a chelate in exchange: the crystal structure of NaHoDOTMA, a 'semi'-hydrated chelate. Chem Commun (Camb). 2013 Mar 21; 49(23):2320-2.